Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Uterine Cervical Neoplasms 1Uterine Cervical Dysplasia 1Pancreatic Neoplasms 1

Interventions

Gemcitabine 3Ethanol 3fish oil triglycerides 2S 1 (combination) 2Metronidazole 2Long-Term Synaptic Depression 2Dexamethasone 2pembrolizumab 1pasireotide 1nimotuzumab 1ferumoxtran-10 1alanylglutamine 1Tobacco Use Cessation Devices 1TachoSil 1Sunitinib 1Psychiatric Rehabilitation 1Pregabalin 1Polymerase Chain Reaction 1Polygeline 1Parenteral Nutrition 1Pancrelipase 1Oxaliplatin 1Nutritional Status 1Needles 1Mirtazapine 1Midazolam 1Meperidine 1Immunonutrition Diet 1Hydrocortisone 1Glucocorticoids 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 4 × Pancreatic Neoplasms × TachoSil × Clear all
NCT03269955 2017-09-01

The Effect of Application of TachoSil® in Pancreatoduodenectomy

Asan Medical Center

Phase 4 Unknown
126 enrolled
Gastrointestinal

Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡